We offer medication sensors and digital tools to upgrade the practice of medicine to make it high-definition and far more individualized. Amiko was born out of insight and inspiration. We believe in the transformative role technology will play in improving healthcare practice. By putting together advanced sensor technologies, seamless connectivity and cutting-edge Artificial Intelligence we deliver our vision of care – to enable and support care professionals with high-definition data and tools, to allow patients to benefit from more personalized care decisions, to generate efficiency and insights in standard practice.
Our first product – a digital therapeutic solution that optimises respiratory therapies using the world’s most advanced smart inhalers
London/Lisbon, UK/PT, 03 July 2018 – Amiko Digital Health Limited (Amiko), a company that develops advanced medication sensor technologies and digital therapeutic solutions
Sanner and Amiko partner to develop digital solutions for true medication adherence Bensheim/Germany, London/UK, 13 February 2018 – How can artificial intelligence, drug
Amiko receives CE mark for use of the Respiro Platform with Teva’s Spiromax® Inhaler, Chiesi’s Nexthaler® inhaler and GlaxoSmithKline’s Ellipta® inhaler London,
Salisbury House, 31 Finsbury Circus, London, UK
Via Washington, 105,